Jessica Tassan
Stock Analyst at Piper Sandler
(1.82)
# 3,284
Out of 4,996 analysts
83
Total ratings
33.33%
Success rate
-7.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Overweight | $33 → $34 | $23.62 | +43.95% | 6 | Sep 5, 2025 | |
| EVH Evolent Health | Maintains: Overweight | $16 → $18 | $8.95 | +101.12% | 4 | Aug 28, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $8 → $4 | $2.80 | +42.86% | 12 | Aug 27, 2025 | |
| PINC Premier | Maintains: Neutral | $24 → $28 | $27.81 | +0.68% | 8 | Aug 25, 2025 | |
| CTEV Claritev | Maintains: Overweight | $44 → $86 | $51.45 | +67.15% | 3 | Aug 15, 2025 | |
| OSCR Oscar Health | Maintains: Neutral | $14 → $13 | $18.42 | -29.42% | 6 | Aug 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $69 | $74.40 | -7.26% | 4 | Aug 11, 2025 | |
| HUM Humana | Maintains: Neutral | $288 → $272 | $254.95 | +6.69% | 4 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $353 → $317 | $344.08 | -7.87% | 8 | Jul 30, 2025 | |
| HNGE Hinge Health | Initiates: Overweight | $41 | $48.46 | -15.39% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $10 → $8 | $6.20 | +29.03% | 3 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $348 → $374 | $286.17 | +30.69% | 4 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $72 → $74 | $75.77 | -2.34% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $17.53 | +19.79% | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $12 | $8.16 | +47.06% | 6 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $30.72 | +127.86% | 4 | Aug 2, 2023 |
Phreesia
Sep 5, 2025
Maintains: Overweight
Price Target: $33 → $34
Current: $23.62
Upside: +43.95%
Evolent Health
Aug 28, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $8.95
Upside: +101.12%
Health Catalyst
Aug 27, 2025
Downgrades: Neutral
Price Target: $8 → $4
Current: $2.80
Upside: +42.86%
Premier
Aug 25, 2025
Maintains: Neutral
Price Target: $24 → $28
Current: $27.81
Upside: +0.68%
Claritev
Aug 15, 2025
Maintains: Overweight
Price Target: $44 → $86
Current: $51.45
Upside: +67.15%
Oscar Health
Aug 14, 2025
Maintains: Neutral
Price Target: $14 → $13
Current: $18.42
Upside: -29.42%
Doximity
Aug 11, 2025
Maintains: Overweight
Price Target: $65 → $69
Current: $74.40
Upside: -7.26%
Humana
Jul 31, 2025
Maintains: Neutral
Price Target: $288 → $272
Current: $254.95
Upside: +6.69%
UnitedHealth Group
Jul 30, 2025
Maintains: Overweight
Price Target: $353 → $317
Current: $344.08
Upside: -7.87%
Hinge Health
Jun 16, 2025
Initiates: Overweight
Price Target: $41
Current: $48.46
Upside: -15.39%
May 23, 2025
Reiterates: Neutral
Price Target: $10 → $8
Current: $6.20
Upside: +29.03%
May 5, 2025
Maintains: Overweight
Price Target: $348 → $374
Current: $286.17
Upside: +30.69%
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $75.77
Upside: -2.34%
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $17.53
Upside: +19.79%
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $8.16
Upside: +47.06%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $30.72
Upside: +127.86%